Isentress (Raltegravir)
| Brand Name: |
Isentress |
| Generic Name: |
Raltegravir, RAL |
| Adult Single Dose: |
One 400-mg tablet twice daily |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
Integrase inhibitor |
|
|
|
The Basics
- An Overview of Isentress (Raltegravir, MK-0518) (September 13, 2012)
From AIDSinfo
- Isentress (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approve U.S. Pediatric Dose for Raltegravir (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Raltegravir (Isentress) (January 13, 2012)
To read PDF, click here.
From AIDS InfoNet
- Merck Lowers Price of Isentress Drug for State AIDS Programs (January 12, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Says Merck's HIV Drug Gets Generic Threat (January 11, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FAQs About Isentress (Raltegravir) (January 4, 2012)
From The Body's "Ask the Experts" Forums
- Isentress (Raltegravir): Pediatric Dosing Recommendations and 2 Chewable Tablet Formulations for Pediatric Dosing (December 21, 2011)
From U.S. Food and Drug Administration
- Patient Information About Isentress (Raltegravir, MK-0518) (PDF) (December 2011)
Prescribing information.
From Merck & Co., Inc.
- Isentress (Raltegravir, MK-0518) Patient Product Information (PDF) (December 2011)
Patient information leaflet.
From Merck & Co., Inc.
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
